Cite
Molecular targets associated with ulcerative colitis and the benefits of atractylenolides-based therapy
MLA
Huanzhu Qian, et al. “Molecular Targets Associated with Ulcerative Colitis and the Benefits of Atractylenolides-Based Therapy.” Frontiers in Pharmacology, vol. 15, May 2024. EBSCOhost, https://doi.org/10.3389/fphar.2024.1398294.
APA
Huanzhu Qian, Zhen Ye, Yu Hu, Mingquan Wu, Liulin Chen, Linzhen Li, Zhipeng Hu, Qian Zhao, Chen Zhang, Maoyi Yang, Wen Xudong, Qiaobo Ye, & Kaihua Qin. (2024). Molecular targets associated with ulcerative colitis and the benefits of atractylenolides-based therapy. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1398294
Chicago
Huanzhu Qian, Zhen Ye, Yu Hu, Mingquan Wu, Liulin Chen, Linzhen Li, Zhipeng Hu, et al. 2024. “Molecular Targets Associated with Ulcerative Colitis and the Benefits of Atractylenolides-Based Therapy.” Frontiers in Pharmacology 15 (May). doi:10.3389/fphar.2024.1398294.